ABBV Covered Call Strategy
ABBV (AbbVie Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation.
ABBV (AbbVie Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $521.50B, a trailing P/E of 50.53, a beta of 0.28 versus the broader market, a 52-week range of 190.75-302.93, average daily share volume of 5.0M, a public-listing history dating back to 2013, approximately 57K full-time employees. These structural characteristics shape how ABBV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.28 indicates ABBV has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 50.53 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. ABBV pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on ABBV?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
ABBV snapshot
As of November 13, 2026, spot at $294.69, ATM IV 25.40%, IV rank 25.52%, expected move 7.28%. The covered call on ABBV below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on ABBV specifically: ABBV IV at 25.40% is on the cheap side of its 1-year range, which means a premium-selling ABBV covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 7.28% (roughly $21.46 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABBV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABBV should anchor to the underlying notional of $294.69 per share and to the trader's directional view on ABBV stock.
ABBV covered call setup
The ABBV covered call below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABBV at $294.69 on that close, the first option leg uses a $310.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABBV chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABBV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $294.69 | long |
| Sell 1 | Call | $310.00 | $3.30 |
ABBV covered call risk and reward
- Net Premium / Debit
- -$29,139.50
- Max Profit (per contract)
- $1,860.50
- Max Loss (per contract)
- -$29,138.50
- Breakeven(s)
- $291.40
- Risk / Reward Ratio
- 0.064
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ABBV covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ABBV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$29,138.50 |
| $65.17 | -77.9% | -$22,622.85 |
| $130.32 | -55.8% | -$16,107.20 |
| $195.48 | -33.7% | -$9,591.56 |
| $260.64 | -11.6% | -$3,075.91 |
| $325.79 | +10.6% | +$1,860.50 |
| $390.95 | +32.7% | +$1,860.50 |
| $456.11 | +54.8% | +$1,860.50 |
| $521.26 | +76.9% | +$1,860.50 |
| $586.42 | +99.0% | +$1,860.50 |
When traders use covered call on ABBV
Covered calls on ABBV are an income strategy run on existing ABBV stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ABBV thesis for this covered call
The market-implied 1-standard-deviation range for ABBV extends from approximately $273.23 on the downside to $316.15 on the upside. A ABBV covered call collects premium on an existing long ABBV position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ABBV will breach that level within the expiration window. Current ABBV IV rank near 25.52% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ABBV at 25.40%. As a Healthcare name, ABBV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABBV-specific events.
ABBV covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABBV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABBV alongside the broader basket even when ABBV-specific fundamentals are unchanged. Short-premium structures like a covered call on ABBV carry tail risk when realized volatility exceeds the implied move; review historical ABBV earnings reactions and macro stress periods before sizing. Always rebuild the position from current ABBV chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ABBV?
- A covered call on ABBV is the covered call strategy applied to ABBV (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ABBV stock at $294.69 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed ABBV chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ABBV covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ABBV covered call priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 25.40%), the computed maximum profit is $1,860.50 per contract and the computed maximum loss is -$29,138.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ABBV covered call?
- The breakeven for the ABBV covered call priced on this page is roughly $291.40 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ABBV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 7.28%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ABBV?
- Covered calls on ABBV are an income strategy run on existing ABBV stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ABBV implied volatility affect this covered call?
- ABBV ATM IV is at 25.40% with IV rank near 25.52%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.